References
Application No. 89/02738 (1989), Izobret. Stran. Mira, Ref. Inform.,15, No. 12, 13 (1989).
USA 4,765,990 (1988), Ref. Zh. Khim., No. 11, Ref. No. 11 0257P (1989).
A. I. Tentsova (ed.), Contemporary Aspects of the Use of Supplementary Materials in Pharmaceutical Technology; Scientific Review [in Russian], Moscow (1981).
A. I. Tentsova and A. E. Dobrotvorskii, Farmacia,30, No. 2, 48–52 (1981).
K. Aoki, S. Kondo, A. Mochizuki, et al., Am. Heart J.,96, 218–226 (1978).
K. Aoki, K. Sato, T. Kawaguchi, and M. Yamamoto, Eur. J. Clin. Pharmacol.,23, 197–201 (1982).
N. Guazzi, M. T. Olivari, A. Pobse, et al., Clin. Pharmacol. Ther.,22, 528–533 (1977).
A. Hasegava, H. Nakagawa, and I. Sugimoto, J. Pharm. Soc. Jpn.,104, 485–489 (1984).
N. Ohnishi, T. Yakoyama, T. Umeda, et al., ibid.,106, 1131–1136 (1986).
I. Sugimoto, A. Kuchiki, and H. Nakagava, Chem. Pharm. Bull.,29, 1715–1723 (1981).
U. S. Pharmacopea, XXII Ed. National Formulary XVII, Washington (1990), pp. 1578–1579.
Author information
Authors and Affiliations
Additional information
Translated from Khimiko-farmatsevticheskii Zhurnal, Vol. 28, No. 11, pp. 51–54, November, 1994.
The authors express thanks to the firms of FMC, ‘Rohm Pharma’, and GAF for all samples of a series of supplementary materials.
Rights and permissions
About this article
Cite this article
Akif'ev, O.N., Gnilomedova, L.E., Bundule, M.F. et al. Technological aspects of treatment of fenigidin tablets to prolong activity. Pharm Chem J 28, 845–849 (1994). https://doi.org/10.1007/BF02218719
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02218719